Erratum: CD4+ T cell'independent DNA vaccination against opportunistic infections (Journal of Clinical Investigation (2005) 115: 12 (3536-3544) DOI: 10.1172/JCI26306);CD4+ T cell-independent DNA vaccination against opportunistic infections

Journal of Clinical Investigation

Volumn 115, Issue 12, 2005, Pages 3536-3544

  Zheng, Mingquan ^a   Ramsay, Alistair J ^b   Robichaux, Myles B ^b   Norris, Karen A ^c   Kliment, Corrine ^a   Crowe, Christopher ^a   Rapaka, Rekha R ^c   Steele, Chad ^a   McAllister, Florencia ^a   Shellito, Judd E ^b   Marrero, Luis ^b   Schwarzenberger, Paul ^b   Zhong, Qiu ^b   Kolls, Jay K ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD4 ANTIGEN; CD40 LIGAND; DNA VACCINE; IMMUNOGLOBULIN G; KEXIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HUMORAL IMMUNITY; IMMUNOPRECIPITATION; MALE; MOUSE; NONHUMAN; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; SCID MOUSE; T LYMPHOCYTE; VACCINATION;

EID: 31044445369     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI81228     Document Type: Erratum

References (33)

1. Morris, A., et al. 2004. Current epidemiology of Pneumocystis pneumonia. Emerging Infect. Dis. 10:1713-1720.
2. Duchini, A., Goss, J.A., Karpen, S., and Pockros, P.J. 2003. Vaccinations for adult solid-organ transplant recipients: current recommendations and protocols. Clin. Microbiol. Rev. 16:357-364.
3. Autran, B., et al. 1997. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science. 277:112-116.
4. Connors, M., et al. 1997. HIV infection induces changes in CD4+ T cell phenotype and depletions within the CD4+ T cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat. Med. 3:533-540.
5. Mackey, M.F., Barth, R.J., Jr., and Noelle, R.J. 1998. The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells. J. Leukoc. Biol. 63:418-428.
6. Ni, K., and O'Neill, H.C. 1997. The role of dendritic cells in T cell activation. Immunol. Cell Biol. 75:223-230.
7. Zheng, M., et al. 2001. CD4(+) T cell-independent vaccination against Pneumocystis carinii in mice. J. Clin. Invest. 108:1469-1474.
8. Lee, L.H., et al. 2000. Molecular characterization of KEX1, a kexin-like protease in mouse Pneumocystis carinii. Gene. 242:141-150.
9. Russian, D.A., et al. 1999. Characterization of a multicopy family of genes encoding a surface-expressed serine endoprotease in rat Pneumocystis carinii. Proc. Assoc. Am. Physicians. 111:347-356.
10. Ramsay, A.J., et al. 1999. Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity. Immunol. Rev. 171:27-44.
11. Rotzschke, O., et al. 1991. Exact prediction of a natural T cell epitope. Eur. J. Immunol. 21:2891-2894.
12. Vance, D.E., and Feingold, D.S. 1971. Additive Edman degradation to sequence small peptides. Nature. 229:121-123.
13. Medzihradszky, K.F., et al. 2000. The characteristics of peptide collision-induced dissociation using a high-performance MALDI-TOF/TOF tandem mass spectrometer. Anal. Chem. 72:552-558.
14. Keely, S.P., Cushion, M.T., and Stringer, J.R. 2003. Diversity at the locus associated with transcription of a variable surface antigen of Pneumocystis carinii as an index of population structure and dynamics in infected rats. Infect. Immun. 71:47-60.
15. Steele, C., et al. 2003. Alveolar macrophage-mediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by the Dectin-1 beta-glucan receptor. J. Exp. Med. 198:1677-1688.
16. Fleming, R.V., Walsh, T.J., and Anaissie, E.J. 2002. Emerging and less common fungal pathogens. Infect. Dis. Clin. North Am. 16:915-933, vi-vii.
17. Kolls, J.K., et al. 1999. IFN-gamma and CD8+ T cells restore host defenses against Pneumocystis carinii in mice depleted of CD4+ T cells. J. Immunol. 162:2890-2894.
18. McAllister, F., et al. 2004. T cytotoxic-1 CD8(+) T cells are effector cells against Pneumocystis in mice. J. Immunol. 172:1132-1138.
19. Banchereau, J., and Steinman, R.M. 1998. Dendritic cells and the control of immunity. Nature. 392:245-252.
20. Grewal, I.S., and Flavell, R.A. 1998. CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16:111-135.
21. Clark, E.A., and Ledbetter, J.A. 1994. How B and T cells talk to each other. Nature. 367:425-428.
22. Kikuchi, T., Worgall, S., Singh, R., Moore, M.A., and Crystal, R.G. 2000. Dendritic cells genetically modified to express CD40 ligand and pulsed with antigen can initiate antigen-specific humoral immunity independent of CD4+ T cells. Nat. Med. 6:1154-1159.
23. Gigliotti, F., Haidaris, C.G., Wright, T.W., and Harmsen, A.G. 2002. Passive intranasal monoclonal antibody prophylaxis against murine Pneumocystis carinii pneumonia. Infect. Immun. 70:1069-1074.
24. Shedlock, D.J., and Weiner, D.B. 2000. DNA vaccination: antigen presentation and the induction of immunity. J. Leukoc. Biol. 68:793-806.
25. Barouch, D.H., Letvin, N.L., and Seder, R.A. 2004. The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responses. Immunol. Rev. 202:266-274.
26. Sumida, S.M., et al. 2004. Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines. J. Clin. Invest. 114:1334-1342. doi:10.1172/JCI200422608.
27. Hollenbaugh, D., et al. 1992. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J. 11:4313-4321.
28. Sad, S., Li, L., and Mosmann, T.R. 1997. Cytokinedeficient CD8+ Tc1 cells induced by IL-4: retained inflammation and perforin and Fas cytotoxicity but compromised long term killing of tumor cells. J. Immunol. 159:606-613.
29. Helmich, B.K., and Dutton, R.W. 2001. The role of adoptively transferred CD8 T cells and host cells in the control of the growth of the EG7 thymoma: factors that determine the relative effectiveness and homing properties of Tc1 and Tc2 effectors. J. Immunol. 166:6500-6508.
30. Cerwenka, A., Morgan, T.M., Harmsen, A.G., and Dutton, R.W. 1999. Migration kinetics and final destination of type 1 and type 2 CD8 effector cells predict protection against pulmonary virus infection. J. Exp. Med. 189:423-434.
31. Patil, S.P., Board, K.F., Lebedeva, I.P., and Norris, K.A. 2003. Immune responses to Pneumocystis colonization and infection in a simian model of AIDS. J. Eukaryot. Microbiol. 50(Suppl.):661-662.
32. Fallaux, F.J., et al. 1996. Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum. Gene Ther. 7:215-222.
33. He, T.C., et al. 1998. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. U. S. A. 95:2509-2514.